Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000777:Anesthetics / Q000494:pharmacology; D000924:Anticholesteremic Agents / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D002400:Cathartics / Q000494:pharmacology; D004071:Digitalis Glycosides / Q000633:toxicity*; D004074:Digitoxin / Q000378:metabolism / Q000633:toxicity; D004077:Digoxin / Q000378:metabolism / Q000633:toxicity; D004232:Diuretics / Q000494:pharmacology; D004347:Drug Interactions; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007475:Ion Exchange Resins / Q000494:pharmacology; D008012:Lidocaine / Q000627:therapeutic use; D008102:Liver Circulation / Q000187:drug effects; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011485:Protein Binding / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D000924:Anticholesteremic Agents; D002400:Cathartics; D004071:Digitalis Glycosides; D004232:Diuretics; D007475:Ion Exchange Resins; D010672:Phenytoin; D004077:Digoxin; D008012:Lidocaine; D004074:Digitoxin; D011188:Potassium; D010634:Phenobarbital